01 January 1998
Assessment of 99mTc-Hepida plasma clearance test evaluation for monitoring of acute and chronic liver diseasesJolanta Białkowska-Warzecha
Med Sci Monit 1998; 4(1): HY153-157 :: ID: 502855
99mTc-Hepida plasma clearance test (HEP-Cl) is a specific and sensitive test of liver function, which has proved to be of much use in assessing the degree of hepatocellular damage. It can be assumed, that this test will also prove useful in monitoring the course of acute and chronic diseases of liver parenchyma and will aid in making the prognosis early in the course of the pathological process. The study was performed on 110 patients, who were divided into three groups (Group I - acute hepatitis type B, Group II - chronic active hepatitis, Group III - cirrhosis of the liver). In all patients the values of HEP-Cl were determined three times. The activity of ALT and GGTP, total bilirubin concentration, serum proteins and electrophoretic fractions were also assessed, as well as markers of infection with hepatitis B virus. The clinical condition of the patients was assessed in the beginning, and at the end of the observation period by means of physical examination. After 6 months of observation 37 patients in Group I recovered (Gr. Ia) and 7 developed chronic hepatitis type B (Gr. Ib). An increase of HEP-Cl was observed in the cases of recovery from acute hepatitis type B. In Group Ib patients exhibited a complete lack of dynamics in HEP-Cl. In the Gr. II and Gr.III effectiveness of treatment from the clinical and biochemical point of view was determined 12-18 months after the observation started. Objective examination included biochemical tests, HEP-Cl inclusive, and liverbiopsy. Youle's coefficient indicated a highly statistically significant correlation (Q=0.78) between clinical assessment and the results of HEP-Cl in chronic active hepatitis, and a lower correlation (Q=0.48) between clinical assessment and the results of HEP-Cl in cirrhosis hepatis. These data indicate that follow up by means of 99mTc-Hepida plasma clearance test is an efficient test for monitoring therapy in acute viral hepatitis type B, and chronic active hepatitis, but of less use in monitoring the course of cirrhosis of the liver.
Keywords: Cirrhosis hepatis, acute and chronic hepatitis, monitoring treatment, plasma clearance, hepida
01 August 2022 : EditorialEditorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic
Med Sci Monit 2022; 28:e937927
05 Aug 2022 : Clinical ResearchA Retrospective Study of 98 Elderly Patients with High-Risk Lateral Femoral Wall Intertrochanteric Hip Frac...
Med Sci Monit In Press; DOI: 10.12659/MSM.936923
05 Aug 2022 : Clinical ResearchHemoglobin/Red Blood Cell Distribution Width Ratio in Peripheral Blood Is Positively Associated with Progno...
Med Sci Monit In Press; DOI: 10.12659/MSM.937146
04 Aug 2022 : Clinical ResearchRadiological Assessment of Prevalance and Quality of Periapical Status of Endodontic Treatments
Med Sci Monit In Press; DOI: 10.12659/MSM.936569
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292